Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The British Journal of Surgery|April 25, 2024
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN studyJames Lucocq, Jake Hawkyard, Beate Haugk, et al.
Surgery|June 25, 2024
Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study)James Lucocq, Nejo Joseph, Jake Hawkyard, et al.
Annals of Surgery|October 24, 2023
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study)James Lucocq, Jake Hawkyard, Francis P Robertson, et al.
Annals of Surgical Oncology|July 3, 2024
Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant ChemotherapyJames Lucocq, Beate Haugk, Daniel Parkinson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 31, 2024
Invasive intraductal oncocytic papillary neoplasms (IOPN) and adenocarcimoma arising from intraductal papillary mucinous neoplasms (A-IPMN) of the pancreas: comparative analysis of clinicopathological features, patterns of recurrence and survival: a multicentre studyJames Lucocq, Beate Haugk, Nejo Joseph, et al.
Annals of Surgery|March 22, 2024
Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched AnalysisJames Lucocq, James Halle-Smith, Beate Haugk, et al.
Pageof 1